Photon Counting CT Market Report Scope & Overview:

The Photon Counting CT Market was valued at USD 1.15 billion in 2025 and is expected to reach USD 8.94 billion by 2035, growing at a CAGR of 22.86% from 2026-2035.

The Photon Counting CT Market is experiencing rapid growth on account of the better image quality, increased spatial resolution, and better material discrimination offered by photon-counting technology relative to the traditional CT equipment. Rising demand for timely and accurate detection of cancer, cardiovascular disease, neurological disease, and other chronic diseases is encouraging the use of this technology in healthcare settings. The ability of the technology to reduce radiation exposure and provide better contrast enhanced imaging is another factor contributing to its increased adoption in the healthcare industry. In addition to this, increasing investments in medical imaging infrastructure, rising application of AI in radiology, developments in photon counting detectors, and rising availability of next generation CT systems are driving growth in the market.

In 2025, a state-of-the-art review identified photon-counting CT applications across cardiovascular, thoracic, abdominal, musculoskeletal, neurological, and pediatric imaging, highlighting the technology’s expanding clinical applications.

Market Size and Forecast:

• Market Size in 2026E: USD 1.40 Billion

• Market Size by 2035: USD 8.94 Billion

• CAGR: 22.86% from 2026 to 2035

• Fastest Growing Region: Asia Pacific

• Largest Region: North America

Photon Counting CT Market Trends:

• Rising adoption of high-resolution diagnostic imaging

• Increasing demand for radiation dose reduction

• Growing use in cardiovascular imaging

• Expansion of spectral and multi-energy CT

• Increasing oncology and precision imaging applications

• Integration of AI-based image reconstruction

• Advancements in photon-counting detector technology

U.S. Photon Counting CT Market Outlook:

The U.S. Photon Counting CT Market was valued at USD 0.43 billion in 2025 and is expected to reach USD 2.96 billion by 2035, growing at a CAGR of 21.48% from 2026-2035.

The U.S. Photon Counting CT Market is experiencing rapid growth This is due to increasing need for high-resolution and low dose medical imaging and increasing use of sophisticated diagnostic techniques. Photon counting CT has superior spatial resolution, better contrast, and improved ability to distinguish materials. The rising cost of healthcare, investments in the infrastructure of advanced imaging, and increasing occurrence of chronic diseases are also contributing factors. Besides this, developments in photon counting detectors, increasing number of clinical studies, the application of artificial intelligence in medical imaging, and increased availability of next generation CT scanners are also contributing to the growth of photon counting CT in the United States.

On November 24, 2025, Photonova Spectra used Deep Silicon photon-counting detector technology with eight energy-resolution bins, enabling high-resolution and spectral imaging across multiple clinical applications.

Photon Counting CT Market Segment Analysis:

• By Product Type, Standalone Photon-Counting CT Systems dominated the Photon Counting CT Market with 72% share in 2025; Retrofit Photon-Counting CT Solutions is expected to grow at the fastest CAGR of 23.90% from 2026–2035.

• By Detector Type, Cadmium Telluride Detectors dominated the Photon Counting CT Market with 67% share in 2025; Cadmium Telluride Detectors is expected to grow at the fastest CAGR of 23.52 % from 2026–2035.

• By Application, Oncology dominated the Photon Counting CT Market with 32% share in 2025; Cardiology is expected to grow at the fastest CAGR of 25.60% from 2026–2035.

• By End User, Hospitals dominated the Photon Counting CT Market with 69% share in 2025; Diagnostic Imaging Centers are expected to grow at the fastest CAGR of 25.58% from 2026–2035.

By Product Type, Standalone Photon-Counting CT Systems dominate the photon counting CT market, Retrofit Photon-Counting CT Solutions grow fastest.

The Standalone Photon-Counting CT Systems segment dominated the Photon Counting CT Market with the highest revenue share of about 72% in 2025 because of increased investments in sophisticated imaging equipment and the need for high-resolution imaging technologies. The capacity of these devices to deliver better spatial resolution, spectral imaging, and decreased radiation doses is a factor that has favored their adoption in hospitals and specialized diagnostic centers.

The Retrofit Photon-Counting CT Solutions segment is expected to grow at the fastest CAGR of 23.90% from 2026–2035, Motivated by the rising need to enhance existing CT technology without a system replacement. Retrofit systems provide hospitals with a cost-effective way to adopt new photon-counting technology without incurring large capital costs. The rise in modernization of imaging centers is contributing to segment growth.

By Detector Type, Cadmium Telluride Detectors dominate the photon counting CT market and grow fastest.

The Cadmium Telluride Detectors segment dominated the Photon Counting CT Market with the highest revenue share of about 67% in 2025 Driven by increasing demand for improving the performance of current CT system without replacement of the system. The retrofitted system gives hospitals an economically viable method to upgrade their photon counting systems without making substantial capital investments. The increase in modernization of imaging centers is fueling the market growth.

The Cadmium Telluride Detectors segment is expected to grow at the fastest CAGR of 23.52% from 2026–2035, backed by rising demands of high resolution spectral imaging and photon counting CTs. Their capacity to detect X-ray photons effectively in different energy ranges allows improved tissue characterization and material differentiation. Innovations in detector technology and increasing adoption are anticipated to boost market growth in the segment.

By Application, Oncology dominates the photon counting CT market, Cardiology grows fastest.

The Oncology segment dominated the Photon Counting CT Market with the highest revenue share of about 32% in 2025 in order to meet the increasing requirement for precise imaging in the diagnosis, staging, therapy planning, and monitoring of cancer patients. The photon-counting CT system is capable of delivering high-resolution imaging, contrast enhancement, and spectral data that will assist in the characterization of tumors with low radiation dose.

The Cardiology segment is expected to grow at the fastest CAGR of 25.60% from 2026–2035, due to increased need for sophisticated cardiovascular imaging and coronary artery disease diagnosis. Photon counting CT allows for enhanced coronary artery imaging and better material differentiation, which is important for plaque analysis and cardiac assessment. Increased incidence of cardiovascular diseases and improvements in cardiac imaging technology are also pushing the trend.

By End User, Hospitals dominate the photon counting CT market, Diagnostic Imaging Centers grow fastest.

The Hospitals segment dominated the Photon Counting CT Market with the highest revenue share of about 69% in 2025 because of their high imaging loads, the presence of healthcare facilities equipped with high-end technology, and more ability to invest in expensive diagnostic machines. More hospitals are using photon-counting CT technology to increase the efficiency of diagnoses in fields such as oncology, cardiology, and neurology.

The Diagnostic Imaging Centers segment is expected to grow at the fastest CAGR of 25.58% from 2026–2035, Backed by the rising demand for more specialized and high quality diagnostic imaging. Increased number of patients, expansion of outpatient imaging facilities, and the development of advanced CT technologies have been driving their adoption. High resolution and spectral imaging capabilities of the photon counting CT are bolstering demand among independent diagnostic centers.

Regional Analysis:

North America Photon Counting CT Market Insights

North America dominated the Photon Counting CT Market with the highest market share of about 42.70% in 2025, driven by advanced healthcare infrastructure, high adoption of next-generation medical imaging technologies, and strong presence of leading CT manufacturers. Significant investments in healthcare modernization, clinical research, and advanced diagnostic imaging, along with increasing demand for high-resolution imaging and early disease detection, further strengthen the region’s market position.

The U.S. Photon Counting CT Market accounted for a market share of 86.80%, supported by increasing investments in sophisticated diagnostic equipment and growing clinical interest in high-resolution, low-radiation-dose CT imaging. Healthcare facilities are upgrading imaging technologies to address the requirements of oncology, cardiology, neurology, and pulmonology applications. Continued healthcare spending, technological advancements, research activities, and rising demand for improved diagnostic imaging are further supporting the adoption of photon-counting CT systems across the United States.

Europe Photon Counting CT Market Insights

The Europe Photon Counting CT Market witnessing significant growth as healthcare systems place greater emphasis on advanced diagnostic imaging, radiation dose reduction, and precision medicine. Some of the important contributors are Germany, United Kingdom, France, and Switzerland, which have good hospital networks, strong medical imaging equipment manufacturing industry, and a sound research base. Growth in the adoption of advanced imaging equipment such as CT scans in various branches of medicine including oncology, cardiology, neurology, and musculoskeletal diagnostics is contributing to the demand.

The Germany Photon Counting CT Market accounted for a market share of 24.6%, supported by the country’s advanced healthcare infrastructure and increasing interest in next-generation medical imaging technologies. Hospitals and medical centers are adopting solutions that provide high-resolution images with reduced radiation exposure. Growing applications in oncology, cardiology, and neurology are further supporting adoption, while Germany’s strong research capabilities, skilled healthcare professionals, and emphasis on accurate diagnosis are contributing to the uptake of photon-counting CT systems.

Asia Pacific Photon Counting CT Market Insights

Asia Pacific is expected to grow at the fastest CAGR of about 26.11% from 2026–2035, supported by expanding healthcare infrastructure, increasing healthcare expenditure, and growing adoption of advanced diagnostic technologies. Rising prevalence of chronic diseases, increasing investments in medical imaging facilities, and government initiatives to modernize healthcare systems are driving demand. Growing awareness of early diagnosis and expanding healthcare access further accelerate photon counting CT adoption across the region.

The China Photon Counting CT Market accounted for a market share of 42.3%, driven by the expansion of hospital and diagnostic facility infrastructure and increased investments in advanced imaging technologies. Demand for photon-counting CT systems is rising due to the need for more accurate and radiation-efficient imaging, particularly for oncology and cardiology applications. Increasing healthcare expenditure, the growing burden of chronic diseases, and improvements in healthcare infrastructure and medical imaging technologies are further supporting market adoption across China.

Middle East & Africa and Latin America Photon Counting CT Market Insights

The Middle East & Africa and Latin America Photon Counting CT Market is developing gradually as healthcare systems increase investments in modern diagnostic infrastructure and advanced medical imaging equipment. Other countries that are playing a role in driving demand in the region include the United Arab Emirates, Saudi Arabia, South Africa, Brazil, and Mexico, through the upgrading and expansion of diagnostic and hospital services. Higher incidences of chronic illnesses and increasing focus on early and proper diagnosis of conditions are providing opportunities for high-end CT technologies.

The UAE Photon Counting CT Market accounted for a market share of 27.1%, supported by continued investments in state-of-the-art healthcare facilities and the implementation of sophisticated diagnostic technologies. Hospitals and imaging centers are upgrading equipment to meet growing demand for advanced CT scanning procedures with improved image quality and lower radiation exposure. Healthcare modernization programs, government initiatives promoting advanced medical technologies, and the UAE’s growing focus on digital healthcare are further supporting the adoption of photon-counting CT systems.

Market Dynamics:

Growth Drivers: Growing adoption of spectral imaging and precision diagnostics is strengthening demand for advanced photon counting CT technology

The growing focus on precision diagnostics is increasing demand for photon-counting CT systems that provide detailed spectral and multi-energy imaging capabilities. Contrary to traditional CT, photon-counting CT will be capable of offering better tissue and material differentiation, and quantitation, thus providing more information for clinicians while diagnosing a patient. This is especially true in case of applications in oncology, cardiology, neurology, and vascular imaging when clear visualization can help diagnose diseases and plan treatment options. In addition, improvements in the field of healthcare infrastructure and modernizing of CT imaging departments in hospitals contribute to better accessibility of advanced CT technologies. Clinical researches, which show the advantages of this technique, promote its implementation into practice as the next generation of CT.

Restraints: High equipment costs and complex installation requirements limit widespread adoption of photon counting CT systems globally

High acquisition and installation costs are a key restraint for the Photon Counting CT Market, because of the need for state-of-the-art semiconductors, advanced image processing techniques, and complicated algorithms involved in generating images. The total expenditure involved is relatively larger than that required for CT scanners. In addition to the cost of acquisition, additional funding may be necessary for making any changes in infrastructure for setting up the machine, installation, integration of the system, and even training of the staff. This can constrain the adoption of such technologies in smaller hospitals and imaging centers that have a limited budget for capital expenses. Reimbursement limitations for some of the advanced imaging services could be another factor.

Opportunities: Expanding applications across oncology and cardiovascular imaging create significant opportunities for photon counting CT adoption

Expanding clinical applications in oncology and cardiovascular imaging are creating significant growth opportunities for the Photon Counting CT Market. In particular, such technologies enable achieving higher spatial resolution, enhanced contrast, spectral imaging, and better visualizability of fine structures. It may result in more effective tumor detection and assessment, vascular imaging, coronary imaging, and visualization of calcifications. This technology may be useful for oncology in terms of improving lesions visualization, diagnosis planning, and treatment monitoring. Cardiology will profit from enhanced visualizability of coronary arteries and less blooming caused by calcifications and stents. With the rise in the incidence of cancer and cardiovascular diseases, the need for more sophisticated diagnostic imaging technologies is constantly growing. Further clinical trials and applications of photon-counting CT in other diagnostic areas are expected to increase its potential.

Recent Developments:

• 2025: Siemens Healthineers announced the first U.S. installation of the NAEOTOM Alpha.Pro, a dual-source photon-counting CT scanner designed to deliver high-resolution imaging at low radiation doses.

• 2025: GE HealthCare unveiled Photonova Spectra, a next-generation photon-counting CT system using proprietary Deep Silicon technology and eight energy-resolution bins to provide detailed spectral information.

• 2025: Canon showcased its photon-counting CT at RSNA 2025, highlighting a next-generation CZT detector platform designed for ultra-high-resolution and spectral imaging with reduced radiation exposure.

• 2025: Kromek advanced its CZT detector development programme for photon-counting CT toward early commercialisation, with collaborations involving leading medical and industrial imaging OEMs.

Photon Counting CT Market key players are:

• Siemens Healthineers

• GE HealthCare

• Philips Healthcare

• Canon Medical Systems Corporation

• United Imaging Healthcare

• Samsung Healthcare / NeuroLogica Corporation

• Fujifilm Healthcare

• Neusoft Medical Systems

• Hitachi Healthcare

• Kromek Group plc

• Spectrum Dynamics Medical

• Planmed Oy

• Bruker Corporation

• Carestream Health

• Konica Minolta, Inc.

• Agfa-Gevaert Group

• Shenzhen Anke High-tech Co., Ltd.

• Analogic Corporation

• Shimadzu Corporation

• Toshiba Medical Systems Corporation

Photon Counting CT Market Report Scope: